Clinical Trials Logo

Male Contraception clinical trials

View clinical trials related to Male Contraception.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06094283 Recruiting - Male Contraception Clinical Trials

First in Human Study Evaluating Single Ascending Oral Doses of YCT-529 in Healthy Males

Start date: December 20, 2023
Phase: Phase 1
Study type: Interventional

A single ascending oral dose(s) study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of YCT-529 in healthy male subjects.

NCT ID: NCT03455075 Recruiting - Healthy Clinical Trials

Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men

Start date: April 16, 2018
Phase: Phase 2
Study type: Interventional

This is a Phase IIa multicenter, double-blind, placebo-controlled study in healthy men to evaluate the spermatogenesis suppression after oral administration of Dimethandrolone Undecanoate (DMAU) alone or with Levonorgestrel (LNG) for 12 weeks versus placebo alone.

NCT ID: NCT02927210 Recruiting - Healthy Men Clinical Trials

Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)

DMAU
Start date: December 2016
Phase: Phase 1
Study type: Interventional

This is a Phase I multicenter, double-blind, single dose, dose-ranging study, in healthy men to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of Dimethandrolone Undecanoate (DMAU) administered as an intramuscular or subcutaneous injection.